6. Parkinson disease Clinical trials / Disease details


Clinical trials : 2,298 Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000019090
2015/11/0401/11/2015Reduced form of CoenzymeQ10 for Parkinson's disease - open trial of dose finding test and combination with hydrogen water Parkinson's diseasereduced form of CoQ10 300mg 16weeks
reduced form of CoQ10 600mg 16weeks
reduced form of CoQ10 600mg 16weeks
hydrogen water 500ml(Suisosui 7.0) 16weeks
Juntendo University Koshigaya HospitalNULLComplete: follow-up complete20years-old80years-oldMale and Female45Not selectedJapan
2NCT00076492
(ClinicalTrials.gov)
January 200423/1/2004NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485A Multi-center, Double-blind, Pilot Study of CoQ10 and GPI 1485 in Subjects With Early Untreated Parkinson's DiseaseParkinson DiseaseDrug: CoQ10;Drug: GPI 1485University of RochesterNational Institute of Neurological Disorders and Stroke (NINDS)Completed30 YearsN/ABoth195Phase 2United States